Document is current
Any future updates will be listed below
-
Authors
Yin, Yi
Li, Shuangshuang
Tong, Jinghui
Huang, Junchao
Tian, Baopeng
Chen, Song
Cui, Yimin
Tan, Shuping
Wang, Zhiren
Yang, Fude
Tong, Yongsheng
Hong, L. Elliot
Tan, Yunlong https://orcid.org/0000-0002-3522-3912
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81761128021, 81771452, 82171507)
Beijing Natural Science Foundation (7151005)
Foundation for the National Institutes of Health (R01MH112180)
- License Information
-
More Information
Article History
Received: 20 September 2021
Revised: 16 April 2022
Accepted: 21 April 2022
First Online: 26 May 2022
Declarations
:
: Dr. Hong has received or is planning to receive research funding or consulting fees from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Sound Pharma, Luye Pharma, Takeda, and Regeneron. None was involved in the design, analysis, or outcomes of the study. Other authors declare that the research was conducted without any relationships that could be interpreted as a potential conflict of interest or financial conflict.
: Written informed consent was provided by adult participants or legal guardians of juveniles.
: All participants provided consent for publication.
: The Institutional Review Board (IRB) of Beijing Huilongguan Hospital, central IRB, approved this research and other research sites accept this approval.
